The FDA has approved a new continuous glucose monitoring system that doubles the time between sensor replacements, making the system more convenient for patients with diabetes.
The agency says that the percutaneous STS-7 system was found to be "safe and effective for detecting trends and tracking patterns of glucose levels in adults" in tests conducted in 72 patients at five clinical sites. The probe measures glucose levels every 5 minutes and has an alarm that can be set to warn of hypo- or hyperglycemia. Patients must replace the sensor weekly; an earlier, 3-day version received FDA approval in March of last year.
FDA Announcement: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01647.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment